5 results
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... ) - Intranasal and ... #Pharmacology # ... #Dosing #Table ... #PAMI
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
Review of Intranasally ... of agents, uses ... , dosing, onset ... #Pain #Medications ... #Pharmacology #
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... kidney), which causes ... #Pharmacology # ... Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #Mellitus #DM2 ... #pharmacology # ... comparison #table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... Toxicities: • Joint pains ... not definitively cause ... #Pharmacology # ... Summary #DM2 #diabetes